PharmaCyte Biotech's total assets for Q were $71.36M, a decrease of -9.53% from the previous quarter. PMCB total liabilities were $22.47M for the fiscal quarter, a 7.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.